Vaishali Shinde

Vaishali Shinde is an accomplished professional in the field of molecular pathology and translational sciences, currently serving as Director and Translational Assay Lead at Corbus Pharmaceuticals since February 2022. Prior experience includes serving as Associate Director and Head of the Molecular Pathology Group at Takeda, where responsibilities encompassed managing biomarker assays for clinical trials, collaborating on translational research strategies, and leading a team in developing innovative technologies. Vaishali's background also includes various roles at Takeda Oncology and Takeda Pharmaceuticals, where significant contributions were made in preclinical studies, immunohistochemistry, and biomarker strategy development. Educational qualifications include an M.S. in Biological Sciences (Biotechnology) from the University of Massachusetts and an M.S. in Microbiology from Shivaji University, India.